Key Highlights and Upcoming Milestones U.S. FDA acceptance of the New Drug Application NDA for Talicia for H. pylori for priority review and assignment of a target PDUFA action date of November 2 2019ÂPreparations ongoing for the potential U.S. commercia...
↧